BIOLINGUS
Biolingus is a Swiss biotech company spearheading the development of oral (sublingual) and mucosal delivery of peptides and proteins. Our technology is derived from applied bio-engineering, resulting in novel bio-mimetic materials. It is a cutting-edge and mature solution for oral formulations not only for peptides but also proteins, novel protein scaffolds, vaccines, immunotherapies, enzymes and also very hydrophobic small molecules. The company focuses the development of its own products ... on treatment of chronic diseases, such as diabetes and inflammatory diseases. In addition to that, a particular area of interest is oral immunotherapy, as our technology has shown an outstanding performance in this area. BioLingus’ main office is in Switzerland, and we have a satellite company in Hong Kong.
BIOLINGUS
Industry:
Biometrics Biotechnology Health Care Medical Device Pharmaceutical Therapeutics
Founded:
2014-07-14
Website Url:
http://www.biolingus.ch
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Font Awesome Apache YouTube ASP.NET IIS Sectigo SSL Sectigo Organization SSL IIS 6
Similar Organizations
4P Therapeutics
4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and therapeutics.
Affinity Biotech
Affinity Biotech is a national specialty pharmacy specializing in bleeding disorders.
Avillion
Avillion LLP, a London, UK-based company that focuses on clinical co-development of therapeutics.
Beaufort
Beaufort is a biotechnology company that specializes in vitro diagnostic,medical device & biopharmaceutical clinical & regulatory services.
Bio-Stream Diagnostics
Bio-Stream's OECT pathogen detection platform offers fast, low-cost point-of-care testing with a pocket-sized Bluetooth reader.
Biocliq Technologies
Biocliq Technologies is a Digital health platform that enables Clinicians, patients, pharmacists and OEMs to Collaborate
Bone Sci Bio
Bone Sci Bio is a medical technology company that specializes in providing delivery platform for bone therapy.
CROS NT
CROS NT is a global team of passionate specialists that deliver innovative, high quality, tailored biometrics solutions.
Epitope Diagnostics
Epitope Diagnostics is a biotechnology company that specializes in chemiluminescence assays and Rapid tests.
LightIR
Changing the way we see cancer by redefining how we treat it.
NOTA Labs
NOTA Labs is a startup company that develops a face mask insert to protect individuals against viral and bacterial pathogens.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Precision Digital Health
Precision Digital Health was created by clinical research insiders who developed a passion for rapidly delivering patient therapies.
Videra Surgical
Videra Surgical is an oncology surgical company that specializes in breast cancer treatment.
Current Employees Featured
Yves Decadt CEO @ BioLingus
CEO
2014-07-14
Thomas KO CTO @ BioLingus
CTO
2014-07-14
Didier Coquoz Chief Development & Regulatory Officer @ BioLingus
Chief Development & Regulatory Officer
2014-07-14
Investors List
RIGHT Fund
RIGHT Fund investment in Grant - BioLingus
Official Site Inspections
http://www.biolingus.ch
- Host name: sl76.web.hostpoint.ch
- IP address: 217.26.52.55
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "BioLingus"
BioLingus
Prior to joining BioLingus, Mr. Hui served as the director of Citylinkers Group, a professional firm in the areas of corporate finance, funding solutions, financial assurance, tax planning, …See details»
BioLingus - Crunchbase Company Profile & Funding
Contact Email info@biolingus.ch Biolingus is a Swiss biotech company spearheading the development of oral (sublingual) and mucosal delivery of …See details»
BioLingus - Swiss Biotech
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins. It is a cutting-edge and mature solution for oral formulations not only for peptides, but also small molecules, …See details»
BioLingus: Disrupting Drug Delivery
BioLingus focuses on the development of products for treatment of metabolic diseases and various immuno-therapies. The firm’s current work explores the development of oral …See details»
HARNESSING NATURE’S INGENUITY BIOLINGUS PAVES …
Deep within Switzerland, a forward-thinking company, BioLingus, is leading the way with a sustainable healthcare vision that could change how biological drugs are delivered. The European Technology Chamber (EUTECH) is proud to …See details»
BioLingus Company Profile - Office Locations, Competitors ... - Craft
BioLingus is a biotechnology company that develops oral and mucosal delivery of peptides and proteins. It offers novel bio-mimetic materials for drug delivery, insulins, liraglutide, exenatide, …See details»
Biolingus IP GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biolingus IP GmbH of Hergiswil NW, NIDWALDEN. Get the latest business insights from Dun & Bradstreet.See details»
BioLingus - VentureRadar
" BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative …See details»
BioLingus | Biotech Careers
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via formulation technology. …See details»
BioLingus
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on …See details»
BioLingus - Overview, News & Similar companies | ZoomInfo.com
Feb 18, 2019 BioLingus contact info: Phone number: +41 786645430 Website: www.biolingus.ch What does BioLingus do? BioLingus is a Swiss biotech company spearheading the …See details»
Needle-free Treatments for Autoimmune Disorders from Switzerland
Jan 27, 2017 Mission: BioLingus develops non-invasive treatments for autoimmune and inflammatory diseases, such as diabetes, Crohn’s and celiac disease.Its therapies are …See details»
BioLingus - Contacts, Employees, Board Members, Advisors
Organization. BioLingus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. BioLingus has 3 …See details»
Biolingus IP GmbH - startup.ch
Biolingus IP GmbH: BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our …See details»
PIPELINE OVERVIEW - biolingus.ch
The following projects are under development by BioLingus. Project 1 : Sublingual Liraglutide (Phase 1b/2a) (BL OPUS I) Project 2 : Sublingual Semaglutide (BL OPUS II) Project 3 : …See details»
Biolingus IP GmbH - startupticker.ch
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative …See details»
BioLingus
BioLingus is spearheading the development of oral (sublingual) and mucosal delivery of peptides and proteins for chronic diseases and immune-therapies. It is a cutting-edge and mature …See details»
BioLingus
Another example of an application of the OPUS technology is the development of a unique "Insulin Plus" formulation. BioLingus' sublingual "Insulin Plus" (sublingual Novolog formulation) …See details»
BioLingus
为了进一步挖掘BioLingus创新技术的潜力，我们乐于与其他制药公司共同开拓合作关系，此外，我们也希望与动物保健与食品公司合作，来开发新型保健品。 我们将共同努力来解锁BioLingus …See details»
BioLingus
Biolingus explores the development of a sublingual dual incretin inhibitor. BioLingus will position these products in the “epidemic” markets of obesity and type II diabetes : - More than 400 MM …See details»